CVE-2024-53348: Loxilb

High severity, CVSS 7.4. EPSS: 0.3% chance of exploitation in the next 30 days.

LoxiLB v.0.9.7 and before is vulnerable to Incorrect Access Control which allows attackers to obtain sensitive information and escalate privileges.

Affected products

• Loxilb Loxilb: up to and including 0.9.7

Published 2025-03-21. Last modified 2026-06-17.